nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Sleep"

 

FDA Approves PTSD Sleep Device for Nightmares
November 11, 2020   

The U.S. Food and Drug Administration granted marketing authorization of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder...
 Continue reading (Members only)
E-Cigarette Use Tied to Sleep Deprivation in Young Adults
October 11, 2020   

The relationship between e-cigarette use and sleep deprivation was recently examined in a sample of young American adults.The findings suggest that e-cigarette use might be associated with...
 Continue reading (Members only)
FDA Requiring Stronger Warning Label For Benzodiazepines
September 25, 2020   

The US Food and Drug Administration has ordered changes to the labeling for benzodiazepines, requiring them to include information on the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions. Benzodiazepines are...
 Continue reading
Use of Benzodiazepines or Z-drugs Not Associated With Subsequent Dementia
May 19, 2020   

Benzodiazepines and Z-drugs are indicated for treatment of affective disorders and insomnia. Due to cognitive side effects of these treatments, their use has been investigated as risk factors for dementia. However, previous investigations have yielded conflicting results...
 Continue reading (Members only)
Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus
April 9, 2020   

With the rising rates of COVID-19 (i.e., severe acute respiratory syndrome coronavirus 2) infection and hospitalization across the world, frontline health care workers will continue to face an overwhelming workload throughout the course of this pandemic. This workload, along with the depletion of personal protection equipment, widespread media coverage, lack of specific drugs and feelings of being inadequately supported may contribute to adverse psychological reactions...
 Continue reading
Morning Blue Light May Aid Sleep and Recovery in Mild Traumatic Brain Injury
February 5, 2020   

Circadian rhythms and adequate sleep are essential to cognitive functioning. Pulses of blue light administered in the morning can re-entrain circadian rhythms and improve sleep difficulties. In a recent double-blind, placebo-controlled study of 32 adult patients with mild traumatic brain injury...
 Continue reading
FDA Approves Lemborexant for Insomnia
January 9, 2020   

Although the exact reason is unknown, sleep is an essential component of both physical and mental health. Unfortunately, approximately 30% of adults suffer from insomnia -the inability to attain or maintain sleep despite adequate opportunity. Not only do insomnia sufferers have...
 Continue reading (Members only)
Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial
October 25, 2019   

A recent 8-week three site double-blind placebo-controlled parallel-group randomized controlled trial was conducted to test whether specific treatment of insomnia...
 Continue reading (Members only)
New Medication Approved For Excessive Daytime Sleepiness in Narcolepsy
August 26, 2019   

Narcolepsy is a disorder of hypersomnolence in which the patient experiences intrusion of sleep during periods of wakefulness; it is often accompanied by excessive daytime sleepiness. On August 14, 2019, the FDA approved the ...
 Continue reading (Members only)
Remember to Sleep: Circadian Function in Alzheimer's Disease
July 2, 2019   

Alzheimer's disease affects approximately 44 million individuals worldwide. This age-related disease is characterized by accumulation of extracellular plaques composed of beta-amyloid protein, intracellular neurofibrillary tangles composed of hyperphosporylated tau protein, severe neuronal loss, and aggressive neuroinflammation. There is currently...
 Continue reading (Members only)
123
Top of Page